JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer

<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">In this JCO Article Insights episode, Peter Li summarizes "<a href= "https://ascopubs.org/doi/abs/10.1200/JCO-24-01676" target="_blank" rel="noopener">Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years</a>," by Dr. Jianwei Zhang et al. published on December 13, 2024.</span></p> <p><span style= "text-decoration: underline; font-size: 12pt; font-family: arial, helvetica, sans-serif;"> <strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong style="mso-bidi-font-weight: normal;"> <span lang="EN" xml:lang="EN">Peter Li:</span></strong> <span lang= "EN" xml:lang="EN">Hello and welcome to the</span> <span lang="EN" xml:lang="EN"><a href= "ht...